河南金丹乳酸科技股份有限公司 2025 年第三季度报告 证券代码：300829 证券简称：金丹科技 公告编号：2025-093 河南金丹乳酸科技股份有限公司 2025 年第三季度报告 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 河南金丹乳酸科技股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 期增减 | | 年同期增减 | | 营业收入（元） | 426,662,779.09 | ...

Core Viewpoint - Guangzhou Chengxin plans to reduce its stake in Jindan Technology through block trading, indicating a strategic move for operational development needs [1] Summary by Relevant Sections Shareholding Changes - Guangzhou Chengxin intends to reduce its holdings by up to 2.3866 million shares, representing 1.05% of the total share capital of Jindan Technology, or 1.07% when excluding repurchased shares [1] - As of the announcement date, Guangzhou Chengxin holds 2.3866 million shares, which is the same percentage of total share capital [1] Previous Transactions - On June 30, 2025, Guangzhou Chengxin had previously reduced its stake by 3.7567 million shares, accounting for 1.65% of the total share capital [1]

Core Viewpoint - Multiple shareholders across various companies are planning to reduce their stakes, indicating potential shifts in investor confidence and market dynamics [1] Shareholder Reductions - Wan Ye Enterprise: Shareholder Sanlin Wan Ye plans to reduce a total of 5.2059 million shares [1] - Kesi Technology: Liang Hongjian intends to reduce 1% of the company's shares [1] - Jindan Technology: Guangzhou Chengxin plans to reduce no more than 2.3866 million shares [1] - Xuantai Pharmaceutical: Qihe Venture plans to reduce a total of 3.131 million shares [1] - Hangzhou Jiebai: Chairman and General Manager Bi Ling plans to reduce a total of no more than 375,000 shares [1] - Jialian Biological: Shareholder UBI plans to reduce no more than 3% of shares [1] - Puyuan Information: Liu Yadong and his concerted actions plan to reduce a total of 0.89% of shares [1] - Zhifan Technology: Director Huang Yong plans to reduce no more than 2.9 million shares [1] - Lanshi Heavy Industry: Shareholder Hualing Xianggang plans to reduce no more than 1% of shares [1] - Biyi Micro: Shareholder Fang Guang Erqi plans to reduce a total of 1.50% of shares [1] - Xinghuo Technology: Shareholder Tie Xiaorong plans to reduce a total of 37.2298 million shares [1] - Henglian Shares: Multiple shareholders plan to reduce their stakes [1] - Jucheng Shares: Wuhan Luojia plans to reduce a total of 4.1241 million shares [1] Financial Performance - Xuanji Information: Reported a net loss of 173 million yuan for the first three quarters [1] - Meilixin: Reported a net loss of 110 million yuan for the third quarter [1]

Group 1 - On October 22, no A-share listed companies disclosed any increase in shareholding [1] - A total of 10 A-share listed companies announced share reductions, including Tai Lingwei, Jindan Technology, Shenlian Biology, Qianyuan Pharmaceutical, Hengsheng Energy, Zhengfan Technology, Lanshi Heavy Industry, Haiguo Co., Ganfeng Lithium, and Hengsuo Co. [1] Group 2 - Tai Lingwei's second largest shareholder, the National Big Fund, plans to reduce its stake by no more than 2% [2] - Jindan Technology's shareholder, Guangzhou Chengxin, intends to reduce its stake by no more than 1.05% [2] - Shenlian Biology's shareholder, UB, plans to reduce its stake by no more than 3% [2] - Qianyuan Pharmaceutical's shareholder, Weng Zhangguo, intends to reduce its stake by no more than 3% [2] - Zhengfan Technology's directors and supervisors plan to collectively reduce their stake by no more than 1.88% [2] - Hengsheng Energy's actual controller has already reduced his stake by 501,600 shares [2] - Lanshi Heavy Industry's shareholder, Hualing Xianggang, plans to reduce its stake by no more than 1% [2] - Haiguo Co.'s shareholder, Yujian Chuangtou, intends to reduce its stake by no more than 0.9965% [2] - Ganfeng Lithium's vice president, Fu Lihua, plans to reduce his stake by no more than 40,000 shares [2] - Hengsuo Co.'s shareholders collectively plan to reduce their stake by no more than 3% [2]

证券日报网讯 10月22日晚间，金丹科技发布公告称，持有公司股份238.66万股，占本公司总股本比例 1.05%（占剔除回购专户股份后总股本比例1.07%）的股东广州诚信创业投资有限公司（简称"广州诚 信"）计划在本公告披露之日起15个交易日后的3个月内（即2025年11月13日至2026年2月12日）以大宗 交易方式减持本公司股份不超过238.66万股，占本公司总股本比例1.05%（占剔除回购专户股份后总股 本比例1.07%）。 （文章来源：证券日报） ...

截至发稿，金丹科技市值为41亿元。 每经头条（nbdtoutiao）——四次登上央视，知名大佬"消失"5年，我们在水果仓库找到了他！从月薪 5000到千亿市值公司联席总裁，他45岁再创业 （记者 曾健辉） 每经AI快讯，金丹科技（SZ 300829，收盘价：17.86元）10月22日晚间发布公告称，持有河南金丹乳酸 科技股份有限公司股份238.66万股，占公司总股本比例为1.05%（占剔除回购专户股份后总股本比例为 1.07%）的股东广州诚信创业投资有限公司计划在本公告披露之日起15个交易日后的3个月内（即2025 年11月13日至2026年2月12日）以大宗交易方式减持公司股份不超过238.66万股，占公司总股本比例为 1.05%（占剔除回购专户股份后总股本比例为1.07%）。 2025年1至6月份，金丹科技的营业收入构成为：食品制造业占比82.6%，农副食品加工业占比9.4%，其 他收入占比7.99%。 ...

金丹科技公告，股东广州诚信创业投资有限公司计划在本公告披露之日起15个交易日后的3个月内（即 2025年11月13日至2026年2月12日）以大宗交易方式减持本公司股份不超过238.66万股，占本公司总股 本比例1.05%（占剔除回购专户股份后总股本比例1.07%）。 (本文来自第一财经) ...

格隆汇10月22日丨金丹科技(300829.SZ)公布，广州诚信计划在本公告披露之日起15个交易日后的3个月 内（即2025年11月13日至2026年2月12日）以大宗交易方式减持本公司股份不超过238.66万股，占本公 司总股本比例1.05%（占剔除回购专户股份后总股本比例1.07%）。 ...

人民财讯10月22日电，金丹科技（300829）10月22日公告，持股1.05%的广州诚信创业投资有限公司计 划以大宗交易方式，减持公司股份不超过238.66万股，占公司总股本的1.05%。 ...

格隆汇10月22日｜金丹科技公告，股东广州诚信创业投资有限公司计划在2025年11月13日至2026年2月 12日期间，以大宗交易方式减持不超过238.66万股，占公司总股本的1.05%。广州诚信目前持有金丹科 技238.66万股，占总股本的1.05%。本次减持的原因是经营发展需要，股份来源为首次公开发行前持有 的股份及资本公积金转增股本取得的股份。减持价格将依据市场价格决定。广州诚信不属于控股股东或 实际控制人，此次减持不会影响公司控制权或治理结构。 ...